Roche Stories

Roche in rare conditions: Working together to create infinite possibilities

Roche is using their new business model, Infinity, to co-create meaningful solutions for people with rare conditions.

The stories of possibilities in rare diseases

Stories of co-creation, collaboration and partnership in our quest to transform the lives of people living with a rare disease.

Roche in the first quarter 2021

Read the update on our first quarter achievements, our efforts related to the COVID-19 pandemic and business performance.

Taking a Leap of Faith

A partnership journey from hope and aspiration to clinical stage biotech.

A Meeting of Scientific Masterminds

Cutting-edge technologies to develop cancer vaccines.

Bridging Academia and Industry

Closing the gap between the bench and the clinic.

Pioneering Novel Therapeutics in Neuroscience

Targeting multiple CNS disorders with siRNA platforms.

Beyond the Deal

Testimonials from our partners sharing insights from their collaborations with Roche and Genentech.

Diagnostics for infectious diseases

Protecting people from pathogens requires innovative strategies, coordinated efforts, and a firm commitment to act.

Diagnostics in cardiometabolic disease

Driving early identification and supporting last-minute intervention with self-management devices as well as digital and diagnostic solutions to help improve the quality of patients’ lives.

Diagnostics in oncology

Every cancer is unique. Throughout each person’s journey, diagnostic testing helps to uncover key insights that support better outcomes.

The value of diagnostics

The quest for better solutions to healthcare’s challenges starts with and depends on diagnostics.

Diagnostics for central nervous system disease

Our efforts in advancing innovative testing strategies are helping to change the future outlook for people with degenerative diseases.

Roche Diagnostics

The quest for better solutions to healthcare’s challenges starts with and depends on diagnostics.

Joining forces in neuroscience

Neurological disorders pose some of the greatest challenges and areas of unmet medical need. We are joining forces with others who are studying these challenges.

‘Blood donor heroes saved my life’

Connie's life was saved when she was just a toddler, thanks to blood donations. Read the story.

Decentralised clinical trials are opening new opportunities

New challenges means new solutions. Clinical research is being redefined in light of COVID-19 and the adoption of decentralised clinical trials

Roche Children’s Walk 2021

Every year our employees around the world join forces to support children in need.

LabCentral Golden Ticket

The winner of the Golden Ticket will be granted access to the facilities of LabCentral, Boston for one year.

Staying connected, so you don’t feel disconnected

Hear from members of the multiple sclerosis community who share their experiences of how connecting with others has helped them to feel supported.

The new normal: Optimising patient care in a virtual world

This page summarises the virtualisation of care whitepaper through the presentation of success stories and healthcare professional perspectives.

Daring to address challenges in Women’s Health

Healthcare systems are failing women. Through this podcast series, we start by asking the hard questions to see why, and where opportunities lie.

Forging ahead so no cancer patient is left behind

Teresa Graham sat down for a virtual chat with Elena Bernedo Arzac, to discuss opportunities in oncology, even amidst current challenges

Asia Partnering at Roche

Our Pharma Partnering team based in China and Japan is actively looking for new partnerships with companies based in Asia.

FutureProofing African healthcare — challenges & innovations

The FutureProofing Healthcare Africa Sustainability Index highlights the conditions faced by African nations as they strive for sustainable healthcare systems.

Haemophilia Treatment for All - A partnership for better access

We celebrate the WFH’s Humanitarian Aid Program, and its mission of improving access to treatment in developing countries.

Finding a new normal after breast cancer

Life changed in an instant for Nicole when she received her breast cancer diagnosis. Learn how this young mom fought the disease.

Delivering fast HIV and COVID-19 test results in Africa

New Roche innovation delivers results for HIV and COVID-19 tests quickly and confidentially to patient smartphones in Sub-Saharan Africa.

Setting personal goals for a future with multiple sclerosis

Understanding your MS can help you in setting small, achievable goals now, which can help you manage your disease, for the future.

Future cures are in our genes

The next generation of pioneering medicines, led by gene therapy, is blazing a path towards truly personalised global healthcare, strengthened by partnering.

The value of Diagnostics in managing COVID-19

4

Widespread, reliable testing can help the world chart a course back to normal life.

Spinal Muscular Atrophy (SMA)

Roche has been working in partnership with the SMA community to transform outcomes for a broad range of people living with the rare, neurological condition.

Managing influenza and COVID-19 during the influenza season

Examining the differences between COVID-19 and influenza and the role Roche has played in the pandemic, including perspectives from Barry Clinch.

Find out what Roche is doing to #PutCancerToTheTest

Roche is raising awareness of cancer genomic testing and the latest advances in personalised healthcare. Find out how you can help #PutCancerToTheTest

For a life beyond NMOSD

Neuromyelitis optica spectrum disorder (NMOSD) can severely affect a person’s quality of life. Find out how the right support can bring stability to their life.

Can wearable technology change the future of neuroscience research?

Scientists are finding new, innovative ways to collect clinical trial data in real-time that will allow regulators to make more accurate, informed decisions

The Roche Institute for Translational Bioengineering

The Roche Institute for Translational Bioengineering in Basel advances the use of new human model technologies in discovery and early phase drug development.

Annual Report 2020 Highlights

How medicines are making an impact in the lives of patients

Roche's innovation and collaboration in ophthalmology

We value the importance of collaboration and innovation to drive change for people living with vision loss and their loved ones

Data can change your life; it probably already has

How data can improve and save lives, and why it matters during the COVID-19 crisis and beyond.

Meet our Roche pRED scientists

Learn more about our scientists and how they are tackling many devastating diseases.

Roche and partners launch free COVID-19 children’s book

A free digital book aims to help parents and caregivers explain ongoing changes due to COVID-19 to children.

Reimagining digital health regulation

9

For timely access to technologies that improve health decisions, health authorities are rethinking regulations for the uniquely iterative world of software.

Living with NMOSD: Advice from a working mother

Ana has neuromyelitis optica spectrum disorder (NMOSD) but has learnt to understand her condition and remain positive. She shares her story here.

Learning about the science behind NMOSD

Understanding neuromyelitis optica spectrum disorder (NMOSD) and the role of interleukin-6 in the inflammation that occurs in people with NMOSD

Neuromyelitis optica spectrum disorder (NMOSD)

NMOSD is a rare and lifelong autoimmune disease of the central nervous system

Progressing health equity in neuroscience

Paulo Fontoura, Global Head of Neuroscience and Rare Diseases Clinical Development, talked to leaders in the neuroscience community about addressing health equity and prioritising D&I

Clinical decision support

6

Transforming complexity into opportunity

The value of clinical decision support

Because patients need certainty.

Two dimensions of confidence in clinical decision making

For patients, a cancer diagnosis changes everything. Former cancer patient Yvonne shares her story and why greater patient access to medical knowledge is critical to improving care.

Roche Accelerator

As Roche’s first in-house accelerator globally, Roche Accelerator aims to serve as an external innovation hub, to catalyze next- generation R&D and contribute to the innovation ecosystem.

Managing disease with diagnostics

Delivering life-changing information across oncology, infectious disease, cardiometabolic disease, central nervous system disease and other areas to help people get the care they need.

How our Diagnostics business works

At Roche Diagnostics, we develop diagnostic tests, instruments and digital solutions with the power to transform healthcare for people around the globe.

Pursuing cancer elimination one cancer type at a time

5

Curing or eliminating cancer for long seemed like a pipe dream. But that is starting to change. Eliminating cervical cancer is within reach.

How One Liver is helping to stop liver disease progression

Millions of people are living with liver disease. Find out how we’re working to tackle chronic liver disease from every angle.

Liver cancer

HCC is known as a ‘silent killer’ as the symptoms often appear too late for curative treatments. Learn more about the signs, symptoms and risk factors.

Roche in Haemophilia

Find out more about haemophilia A and how Roche is working closely with the community to transform haemophilia care.

Increasing access to healthcare

Groundbreaking advances in medical science are only meaningful when they reach the people who need them.

Patient partners

To do our best for patients, we need to work with them. Learn more about the importance of patient partnerships in shaping the future of healthcare

Pandemic-proof patient advocacy

How COVID-19 has changed the world of a patient leader When work involves advocating for diseases other than COVID-19, the pandemic presents an additional barrier to overcome.

The continuing evolution of clinical trials

Nowadays, clinical trials are highly structured and regulated, ensuring the safety of the participants, but this hasn't always been the case.

Roche in complement-mediated diseases

What happens when the complement system, a vital part of the immune system, is not properly regulated? Learn more about complement-mediated diseases.

Revolutionising clinical research through digital innovation

Can smartphone apps help us solve unanswered questions in rare diseases? Roche’s Scott Schobel discusses recent innovations in Huntington’s disease research.

Taking control of IPF: A tale of two perspectives

Rainer, who was diagnosed with idiopathic pulmonary fibrosis (IPF) after two stressful years of uncertainty, tells his story on living with IPF alongside expert advice from his doctor.

Pregnancy after preeclampsia

Is it safe to have another baby?

Let’s talk fertility

Women and their bodies may have very different ideas about the right time to have a baby.

Women’s health at every stage of life

Every woman’s journey through life is her own, yet all face similar choices and challenges. Health is critical at every stage of this journey.

The many faces of breast cancer

Each women is unique. But breast cancer doesn’t care. It can happen to anyone. And when it does happen, each woman’s breast cancer is as individual as she is.

Cancer genomic testing – Jamal Tamer’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient Jamal Tamer about the real-world impact it can have.

Cancer genomic testing – Debbie Rhea’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient Debbie Rhea about the real-world impact it can have.

ForPatients

Developed in partnership with patients, ForPatients aims to support patients on their journey.

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Organoids: turning science fiction to reality

The Roche Institute for Translational Bioengineering (ITB) is accelerating research into using organoids to predict the safety and efficacy of new molecules.

Discover Roche’s latest innovations in cancer immunotherapy

Roche scientists discuss their work at the cutting edge of cancer immunotherapy research

Roche in Neuroscience & Rare Disease: Preserving what makes people who they are

Our mission is rooted in our formula: follow the science to preserve what makes people who they are.

For cancer patients, personalised care matters more than ever

Mobile blood draw programs bring comprehensive genetic profiling and personalised care to cancer patients – the hidden victims of the pandemic

Our Approach to Cancer Immunotherapy

Roche are leading in cancer immunotherapy through innovative research, including immune profiling, with the goal to develop treatment tailored to individuals.

The next chapter of breast cancer treatment

George Gauthier reflects on the extraordinary 30-year journey Roche has travelled in breast cancer, and the hugely exciting potential destinations of the future.

A woman's right to know: HPV and cervical cancer

The HPV test came back positive – what now? Should women be worried? What should they do next?

Uncovering stories of progression from the MS community

The MS community shares what they want others to know about the often invisible symptoms of MS, as well as their journey to managing its hidden impact.

Personalised Healthcare

We are taking PHC toward a future where treatments are targeted to an individual’s needs and unique genetic profile.

What is IBD?

IBD is a group of complex, chronic conditions, characterised by prolonged inflammation of the gastrointestinal tract, which can have a long-term impact on a patient's quality of life.

Climate change is a very real threat

London is vulnerable to climate change

The beginning of a new normal

Wildfires and heat waves have become normal

We are used to breathing trouble

Smog is a constant companion in Delhi

Roche in Alzheimer’s disease

Alzheimer’s disease has far-reaching impact on individuals, caregivers, families and society. Learn how Roche is tackling this looming global crisis.

Tip of the iceberg: the hidden impact of Alzheimer’s disease

Caring for people with Alzheimer’s disease has a huge economic and emotional impact. Learn about the intangible costs and Freeha’s experience with her father.

External innovation opens new doors for advancing science

Global Head of Pharma Partnering James Sabry is excited to embrace the potential of external innovation and innovative partners.

Recognise the impact of flu

Flu is one of the most common infectious diseases, representing a serious threat to public health.

The hidden impact of flu: Allison’s story

Allison Miller was living a normal life when complications arising from the flu changed everything.

Reimagining breast cancer with a new palette of pink

Each woman has her own story of cancer, her own shade of pink. We explore the stories of different women who share their unique experience with breast cancer.

Autism Spectrum Disorder: A journey with unique challenges

Kathy Hyde hopes that telling her son’s story will help increase understanding of the challenges faced by individuals with autism spectrum disorder.

Will genomics revolutionise the future of medicine?

Joanne Hackett talks about genomics, healthcare, big data and people’s hesitation to share medical data.

Will quantum computers solve the problems of the future?

Martin Strahm talks about the idea, the potential and the limitations of quantum computers.

Building bridges to improve the cancer patient journey

The role of an oncology nurse navigator requires a unique combination of skills, knowledge and compassion.

Our approach to sustainability

Our response to cancer always starts with the science

Targeting cancer demands a deep understanding of its complexities. Our researchers have the freedom to explore cutting-edge science & technology to achieve this.

Understanding the role of the microbiome in IBD

Unlocking the mysteries of the gut’s unique and diverse environment of micro-organisms to help improve patient treatment outcomes.

A journey towards mutual understanding in IBD

A look at the importance of patient-physician communication in ulcerative colitis and Crohn’s disease, and how we are developing digital tools to help address this.

Piecing together the puzzle of IBD

Read how we are approaching personalised healthcare in IBD to support individualised care for people living with ulcerative colitis and Crohn’s disease.

Roche's personalised approach in IBD

Compare today's approach in IBD with the ideal future

Changing the colorectal cancer story

Two days after being admitted to hospital with stomach pains, Eve Bukowski woke up to the news we all fear.

Shedding light on progression in MS

How Roche is paving the way for better understanding of MS disease progression and monitoring.

The role of diagnostics in fertility and pregnancy

Learn more about advanced screening and diagnostics tests and their role in preconception and pregnancy.

About the importance of disease awareness

Four key factors need to be in place to successfully treat a patient, the first factor is disease awareness.

Hepatitis B - Aiming for cure of a killer

Hepatitis B is responsible for more than 800,000 deaths a year. Roche is working on a cure.

Striking back at stroke risk

Why less is more in atrial fibrillation management

Addressing the lack of cancer care in Pakistan

Our access to healthcare initiatives

Explore some of our access projects from around the globe.

Increasing access to healthcare is a global challenge

Finding sustainable solutions to the barriers to healthcare can only be achieved through collaboration.

The NT-proBNP Story

Biomarkers play a crucial role in Roche’s commitment to personalised healthcare. To find them, we rely on the promising research of our external partners.

Improving access to hepatitis treatment in Egypt

Comprehensive access to cancer treatment in Dubai

A platform for supporting cancer patients in India

India does not have a centralised healthcare funding body and access to medicines is not universal.

Improving cancer care in Bosnia and Herzegovina

Strengthening communities

We are committed to building stronger communities and responding to natural disasters sustainably.

Our approach to philanthropy

We engage in philanthropic activities that make a lasting impact and strengthen communities.

Better together: Helping one million people with diabetes

Ask anybody with diabetes: managing it is time consuming, exhausting and very annoying.

Of bonds and benefits

Two made-in-Japan collaborations strengthen both Roche and its partners.

Making HIV testing accessible

The Global Access Programme makes HIV viral load tests and the early detection of infections in infants possible in countries that are most affected by the disease.

About the importance of funding

Four key factors need to be in place to successfully treat a patient, with funding being the most controversial one.

About the importance of healthcare capacity

Healthcare capacity is one of four key factors that need to be in place to successfully treat a patient.

About the importance of diagnosis

Four key factors need to be in place to successfully treat a patient, with diagnosis being one of them.

Our approach to increase access to healthcare

Access to healthcare is a complex challenge. Four key factors need to be in place to improve access to quality healthcare.

Always trying to err on the side of drug safety

Keeping its medicines safe for the people who need them is at the core of our remit.

Digital solutions supporting rheumatoid arthritis community

It has become natural for people to seek information or advice about their health online. Learn about three solutions we developed for the European RA community.

Mesothelioma: What could possibly link this rare cancer to the ill-fated Titanic?

What could possibly link this rare cancer to the ill-fated Titanic?

Busting myths in lung cancer

How much do you really know about lung cancer? Our interactive flashcards bust some common myths about lung cancer.

Expecting more for people with PPMS

Dr. Jerome de Seze, explains how recent clinical advances mean more and more people are being diagnosed with PPMS.

MS measurements explained

How we define the ways in which multiple sclerosis can be measured.

Primary progressive MS: Different perspectives

Dr. de Seze and Craig Milverton, who lives with primary progressive multiple sclerosis (PPMS), share their experiences managing and living with this form of MS.

The realities of pursuing the cure for cancer

Cindy Perettie, our Global Head of Oncology Strategy, provides her personal perspective on the challenges of leading the cure for cancer.

Protecting against progression

Dr. Traboulsee, University of British Columbia in Vancouver, discusses the importance of brain health and early treatment for people with multiple sclerosis.

Beyond the immunity cycle

Roche’s scientists are leading pioneers in immune biology and cancer research, which is resulting in innovative and personalised treatment options in cancer.

Creating value through partnerships

Partnering builds on our culture, one in which we listen to a potential partner and structure a collaboration that meets both parties’ needs.

Buttons - daily enemies for people with rheumatoid arthritis

New clothing collection designed to overcoming issues that people with RA face when getting dressed.

Rheumatoid arthritis through the lens of an Slovenian artist

A photographer captures what it means to live with the consequences of rheumatoid arthritis.

Providing a helping hand for people with rheumatoid arthritis

A collaboration with the Brazilian patient advocacy group helps to improve the quality of life of people living with RA.

Life with rheumatoid arthritis through pictures and words

The three artists captured what living with the disease means to people with rheumatoid arthritis.